Pharmacy Times
NOVEMBER 23, 2024
Intravenous immunoglobulin (IVIG) has proven efficacy in autoimmune neuropathies, with mixed but promising outcomes in severe COVID-19 cases and post-acute sequelae of SARS-CoV-2 infection trials.
STAT
NOVEMBER 23, 2024
A conservative federal judge in Texas has ruled in favor of UnitedHealth Group, saying the federal government unlawfully factored in a “disputed” phone call to lower UnitedHealth’s Medicare Advantage ratings. The Centers for Medicare and Medicaid Services will now have to revise UnitedHealth’s 2025 Medicare Advantage ratings by taking out the call center metric, and “immediately publish the recalculated star ratings in the Medicare Plan Finder,” Ju
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
NOVEMBER 23, 2024
Belantamab mafodotin demonstrated benefits in overall survival in the phase 3 DREAMM-7 trial.
STAT
NOVEMBER 23, 2024
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
NOVEMBER 23, 2024
Data show that a child’s insurance status is independently associated with mortality after hematopoietic cell transplantation.
STAT
NOVEMBER 23, 2024
STAT reporters reached out to key figures in biotech, pharma, and medical devices to find out what they think about President-elect Trump’s pick of Johns Hopkins pancreatic surgeon Martin “Marty” Makary as commissioner of the Food and Drug Administration. Makary, like Trump’s intended Health and Human Services selection, Robert F.
Expert insights. Personalized for you.
169 
Let's personalize your content